All News
FDA clears Moderna’s RSV vaccine for use in people aged 18 to 59
The FDA expanded the approval of Moderna’s RSV vaccine, extending the license to include more adults and giving the company a welcome win.
Read MoreSickle cell patients to have quicker and more accessible treatment in England
Government announces £9m funding to make specialist blood machines more widely available across NHSPeople living with sickle cell disease in England are to benefit from quicker and more accessible tr
Read MoreThe upheaval of CDC’s vaccine panel, and drug pricing confusion
This week on "The Readout LOUD": Why did RFK Jr.
Read MoreSTAT+: Trump administration demands pharma companies begin drug price negotiations, a day after key deadline
Trump wants drug companies to bring their prices in line with what other countries pay.
Read MoreDocs Should Turn Away From ACIP's Vaccine Recommendations, Ex-Member Says
(MedPage Today) -- A recently ousted member of the CDC's Advisory Committee on Immunization Practices (ACIP) said Thursday that she is recommending that physicians go to sources other than ACIP for v
Read MoreRFK Jr. Plans to Pull Medical Schools' Funding if They Don't Teach Nutrition
(MedPage Today) -- HHS Secretary Robert F. Kennedy Jr. said in April that he plans to tell medical schools to teach nutrition or risk losing federal funding, ABC News reported last week.
Read MoreSTAT+: Pharma wins a victory over a Minnesota law designed to provide transparency into drug pricing
Once again, Pharma fends off an effort by a state to impose more transparency on drug pricing.
Read MoreEarly FIT Linked to Reduced Colon Cancer Incidence, Mortality
(MedPage Today) -- Starting fecal immunochemical testing (FIT) at ages 40 to 49 was associated with reduced colorectal cancer (CRC) incidence and mortality compared with starting screening at age 50,
Read MoreSystematic reviews cited retracted articles, new study finds
A new study found some systematic reviews included retracted studies from paper mills, journals that produce low quality research
Read MoreMavyretz Approved for Acute Hepatitis C; ALD Deaths Double; Entyvio in Pregnancy
(MedPage Today) -- The FDA expanded the approval of the direct-acting antiviral (DAA) glecaprevir/pibrentasvir (Mavyret), making it the first treatment for acute hepatitis C virus, AbbVie announced.
Read More